Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local Methylprednisolone in MIS TLIF
NCT03308084Phase 3Completed
- Sponsor
- Rush University Medical Center
- Start
- Nov 2015
- Primary completion
- May 2019
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of methylprednisolone injection in radiculopathy, spinal stenosis, herniated nucleus pulposus (HNP), degenerative disc disease (DDD), spondylosis, sponsored by Rush University Medical Center. Started Nov 2015; status: completed.
02
Drugs
methylprednisolone injection
03
Conditions
radiculopathyspinal stenosisherniated nucleus pulposus (HNP)degenerative disc disease (DDD)spondylosis
Beyond the preview
Go deeper on NCT03308084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03308084.